back to homepage


AHIP CEO: Industry Must Address Rising Rx Drug Costs

Health care industry stakeholders should “begin talking” about addressing rising prescription drug costs before the federal government is forced to step in, according to America’s Health Insurance Plans President and

Read More

Published Report: FDA on GDUFA

The FDA has released its Performance Report for the first year of the Generic Drug User Fee Amendments (PDF downloadable at

Read More

Careers … Young Scientist Scholarship Launched by iIroko Pharma & Penn

New Initiative Designed to Reward Philadelphia Students Pursuing Higher Education in the Sciences.

Read More

FDA Approves Xalkori for Late-stage Lung Cancer

The U.S. Food and Drug Administration today approved Xalkori (crizotinib) to treat certain patients with late-stage (locally advanced or metastatic), non-small cell lung cancers (NSCLC) who express the abnormal anaplastic

Read More

The Impact of Health Care Reform on the Pharmaceutical Industry

Overview Under the Affordable Care Act, President Obama signed into law the Patient Protection and Affordable Care Act (PPACA) on March 23, 2010. The PPACA proposes to extend healthcare to

Read More